The relationship of hemoglobin A1C to time-in-range in patients with diabetes

RA Vigersky, C McMahon - Diabetes technology & therapeutics, 2019 - liebertpub.com
Background: There has been recent recognition of the limitations of hemoglobin A1C
(HbA1C) in describing both short-and long-term glycemic control. Continuous glucose …
被引用次数：472 相关文章

[引用][C] The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes

RA Vigersky, C McMahon - Diabetes Technology & Therapeutics, 2019 - cir.nii.ac.jp
The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.

RA Vigersky, C McMahon - Diabetes Technology & Therapeutics, 2018 - europepmc.org
Background There has been recent recognition of the limitations of hemoglobin A1C
(HbA1C) in describing both short-and long-term glycemic control. Continuous glucose …

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes

RA Vigersky, C McMahon - Diabetes technology & …, 2019 - pubmed.ncbi.nlm.nih.gov
Background There has been recent recognition of the limitations of hemoglobin A1C
(HbA1C) in describing both short-and long-term glycemic control. Continuous glucose …